The creation of retatrutide, a novel dual agonist targeting both GLP-1 and GIP receptors, represents a complex several-stage organic process. Early routes focused on protein fragment coupling, utilizing solid-phase https://elodierfkx545200.azzablog.com/41138291/creation-and-research-implementations-of-retatrutide